2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium

Transfusion

Volumn 55, Issue 9, 2015, Pages 2282-2290

  Spitalnik, Steven L ^a   Triulzi, Darrell ^b   Devine, Dana V ^c   Dzik, Walter H ^d   Eder, Anne F ^e   Gernsheimer, Terry ^f   Josephson, Cassandra D ^g   Kor, Daryl J ^h   Luban, Naomi L C ⁱ   Roubinian, Nareg H ^j   Mondoro, Traci ^k   Welniak, Lisbeth A ^k   Zou, Shimian ^k   Glynn, Simone ^k   Zimring, J C ^l   Yazdanbakhsh, K ^l,l   Delaney, M ^l   Ware, R E ^l   Tinmouth, A ^l   Doctor, A ^l   Migliaccio, A R ^l   Fergusson, D A ^l   Widness, J A ^l   Carson, J L ^l   Hess, J ^l   Roback, J D ^l   Waters, J H ^l   Cancelas, J A ^l   Gladwin, M T ^l   Rogers, M A ^l   Ness, P M ^l   Rao, S ^l   Watkins, T R ^l   Spinella, P C ^l   Kaufman, R M ^l   Slichter, S J ^l   McCullough, J ^l   Blumberg, N ^l   Webert, K E ^l   Fitzpatrick, M ^l   Shander, A ^l   Corash, L M ^l   Murphy, M ^l   Silberstein, L E ^l   Dumont, L J ^l   Mitchell, W ^l   Macdonald, V W ^l   Hoffmeister, K M ^l   Italiano, J E ^l   Gupta, A S ^l   Wu, Y ^l   Cap, A P ^l   Li, R ^l   Goodrich, R P ^l   Morrell, C N ^l   Semple, J W ^l   Kahr, W H ^l   Tanaka, K ^l   Haas, T ^l   Sperry, J L ^l   Callum, J L ^l   Porte, R J ^l   Mallett, S ^l   Gajic, O ^l   Juffermans, N P ^l   Karam, O ^l   Vlaar, A P ^l   Looney, M R ^l   Inaba, K ^l   Shaz, B H ^l   Hunt, B J ^l   Cohen, M J ^l   Kitchens, C S ^l   Stanworth, S J ^l   Bryant, B J ^l   Kiss, J E ^l   Busch, M P ^l   Dodd, R Y ^l   Heddle, N M ^l   Spencer, B R ^l   Keller, A J ^l   Germain, M ^l   Goldman, M ^l   Tomasulo, P A ^l   de Kort, W ^l   Mast, A E ^l   Francis, R O ^l   more..

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e AMERICAN RED CROSS   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Mayo Clinic   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ALLOIMMUNITY; ANEMIA; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; CANCER CHEMOTHERAPY; CANCER PATIENT; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; FUNCTIONAL STATUS; HUMAN; INTERNATIONAL NORMALIZED RATIO; INVASIVE PROCEDURE; IRON DEFICIENCY; MORTALITY; NATIONAL HEALTH ORGANIZATION; PLASMA TRANSFUSION; QUALITY OF LIFE; RESUSCITATION; REVIEW; STORAGE; THROMBOCYTE TRANSFUSION; TRANSFUSION MEDICINE; VISCOELASTICITY; ANIMAL; BLOOD TRANSFUSION; ORGANIZATION; UNITED STATES;

ANIMALS; BLOOD TRANSFUSION; CONGRESSES AS TOPIC; HUMANS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); UNITED STATES;

EID: 84941804929     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13250     Document Type: Review

References (56)

1. Higgins JM, Sloan SR., Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112: 2546-53.
2. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F., Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120: 528-37.
3. Rosse WF, Gallagher D, Kinney TR, et al., Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76: 1431-7.
4. Aygun B, Padmanabhan S, Paley C, et al., Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
5. Kacker S, Ness PM, Savage WJ, et al., Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion 2014; 54: 2034-44.
6. Cancelas JA, Dumont LJ, Maes LA, et al., Additive solution-7 reduces the red blood cell cold storage lesion. Transfusion 2015; 55: 491-8.
7. Salunkhe V, van der Meer PF, de Korte D, et al., Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus Apher Sci 2015; 52: 19-34.
8. Daley GQ., Deriving blood stem cells from pluripotent stem cells for research and therapy. Clin Haematol 2014; 27: 293-7.
9. Rousseau GF, Giarratana MC, Douay L., Large-scale production of red blood cells from stem cells: what are the technical challenges ahead? Biotechnol J 2014; 9: 28-38.
10. Mercier Ythier J., Cultured blood versus donated blood: long-run perspectives of the economy of blood. Biomed Mater Eng 2015; 25: 199-209.
11. Carson JL, Carless PA, Hebert PC., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
12. Carson JL, Brooks MM, Abbott JD, et al., Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-71.
13. Shander A, Javidroozi M, Naqvi S, et al., An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014; 54: 2688-95.
14. Rohde JM, Dimcheff DE, Blumberg N, et al., Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311: 1317-26.
15. Valeri CR, Cassidy G, Pivacek LE, et al., Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-83.
16. Bercovitz RS, Quinones RR., A survey of transfusion practices in pediatric hematopoietic stem cell transplant patients. J Pediatr Hematol Oncol 2013; 35: e60-3.
17. Webert KE, Cook RJ, Couban S, et al., A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008; 48: 81-91.
18. Doctor A, Spinella P., Effect of processing and storage on red blood cell function in vivo. Semin Perinatol 2012; 36: 248-59.
19. Goodnough LT., Blood management: transfusion medicine comes of age. Lancet 2013; 381: 1791-2.
20. Goodnough LT, Levy JH, Murphy MF., Concepts of blood transfusion in adults. Lancet 2013; 381: 1845-54.
21. Vallet B, Adamczyk S, Barreau O, et al., Physiologic transfusion triggers. Clin Anaesthesiol 2007; 21: 173-81.
22. Marshall JC., Transfusion trigger: when to transfuse? Crit Care 2004; 8 Suppl 2: S31-3.
23. Sahler J, Grimshaw K, Spinelli SL, et al., Platelet storage and transfusions: new concerns associated with an old therapy. Drug Discov Today Dis Mech 2011; 8: e9-14.
24. Chin JL, Hisamuddin SH, O'Sullivan A, et al., Thrombocytopenia, platelet transfusion, and outcome following liver transplantation. Clin Appl Thromb Hemost 2014; [Epub ahead of print].
25. Kumar A, Mhaskar R, Grossman BJ, et al., Platelet transfusion: a systematic review of the clinical evidence. Transfusion 2015; 55: 1116-27.
26. Whitlock R, Crowther MA, Ng HJ., Bleeding in cardiac surgery: its prevention and treatment-an evidence-based review. Crit Care Clin 2005; 21: 589-610.
27. Christensen MC, Dziewior F, Kempel A, et al., Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26: 46-51.
28. Spinella PC, Holcomb JB., Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009; 23: 231-40.
29. Slichter SJ, Corson J, Jones MK, et al., Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood 2014; 123: 271-80.
30. Grozovsky R, Hoffmeister KM, Falet H., Novel clearance mechanisms of platelets. Curr Opin Hematol 2010; 17: 585-9.
31. Anselmo AC, Modery-Pawlowski CL, Menegatti S, et al., Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 2014; 8: 11243-53.
32. Lambert MP, Sullivan SK, Fuentes R, et al., Challenges and promises for the development of donor independent platelet transfusions. Blood 2013; 121: 3319-24.
33. Carr R, Hutton JL, Jenkins JA, et al., Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990; 75: 408-13.
34. Blumberg N, Heal JM, Hicks GL Jr, et al., Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001; 41: 790-3.
35. Shanwell A, Andersson TM, Rostgaard K, et al., Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang 2009; 96: 316-23.
36. Inaba K, Branco BC, Rhee P, et al., Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 2010; 145: 899-906.
37. Muller MC, Arbous MS, Spoelstra-de Man AM, et al., Transfusion of fresh-frozen plasma in critically ill patients with coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion 2015; 55: 26-35.
38. Callum J, Dzik WH., The use of blood components prior to invasive bedside procedures: a critical appraisal. In:, Mintz PD, editor. Transfusion therapy: clinical principals and practice. 3rd ed. Bethesda (MD): AABB Press; 2010.
39. Rodger M, Ramsay T, Fergusson D., Diagnostic randomized controlled trials: the final frontier. Trials 2012; 13: 137.
40. Weber CF, Görlinger K, Meininger D, et al., Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47.
41. Hunt BJ., Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370: 847-59.
42. Innerhofer P, Westermann I, Tauber H, et al., The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-16.
43. Arnold DM, Donahoe L, Clarke FJ, et al., Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med 2007; 30: E93-102.
44. Shuja F, Shults C, Duggan M, et al., Development and testing of freeze dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008; 65: 975-85.
45. Lee TH, Van PY, Spoerke NJ, et al., The use of lyophilized plasma in a severe multi-injury pig model. Transfusion 2013; 53 Suppl 1: 72S-9S.
46. Shuja F, Finkelstein RA, Fukudome E, et al., Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2011; 70: 664-71.
47. Nascimento B, Callum J, Tien H, et al., Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 2013; 185: E583-9.
48. Holcomb JB, Tilley BC, Baraniuk S, et al., Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. JAMA 2015; 313: 471-82.
49. Food and Drug Administration. Draft Guidance for Industry: revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products. Silver Spring (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; May 2015.
50. Stein J, Besley J, Brook C, et al., Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang 2011; 101: 277-81.
51. Mast AE, Schlumpf KS, Wright DJ, et al., Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica 2013; 98: 1324-30.
52. Cable RG, Glynn SA, Kiss JE, et al., Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2012; 52: 702-11.
53. Raval JS, Waters JH, Seltsam A, et al., Menopausal status affects the susceptibility of stored RBCs to mechanical stress. Vox Sang 2011; 100: 418-21.
54. Heddle NM, Eikelboom J, Liu Y, et al., Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses. Transfusion 2015; 55: 364-72.
55. Eder AF, Hillyer CD, Dy BA, et al., Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 2008; 299: 2279-86.
56. Bravo M, Kamel H, Custer B, et al., Factors associated with fainting-before, during and after blood donation. Vox Sang 2011; 101: 303-12.